Is this your brand? Sign in to claim ownership.
Sign in to claim this brandInformation
- Country
- US
- Address
- —
- Website
- —
- —
- —
- —
- Phone
- —
- PRRC Contact
- —
- EUDAMED SRN
- —
- FDA FEI Number
- —
- DUNS Number
- —
Catalogue (146)
Page 2 of 3| Device | Model / Reference | Registries | Class | Status |
|---|---|---|---|---|
| Ovitex® PRS | R20253-1122G | FDA UDI | Class II | Unknown |
| Myriad Morcells™ | PW01NA0200 | FDA UDI | U | Active |
| Myriad Meshed Expandable Bioscaffold | MS01FV1822 | FDA UDI | U | Active |
| Ovitex® PRS | R30353-1622G | FDA UDI | Class II | Unknown |
| Endoform Myriad | MR05LG1010 | FDA UDI | Class II | Unknown |
| Ovitex® PRS | R20343-2022P | FDA UDI | Class II | Unknown |
| Ovitex® PRS | R20353-1622G | FDA UDI | Class II | Unknown |
| Endoform Antimicrobial Dermal Template | 629313 | FDA UDI | U | Active |
| Endoform™ Natural Restorative Bioscaffold | 529315 | FDA UDI | U | Active |
| Myriad Morcells™ | PW02NA0050 | FDA UDI | U | Active |
| Ovitex® PRS | R30353-2022G | FDA UDI | Class II | Unknown |
| Restella | R20253-1020G | FDA UDI | Class II | Unknown |
| Endoform Natural Dermal Template | 529304 | FDA UDI | U | Active |
| Ovitex® PRS | R20353-2025G | FDA UDI | Class II | Unknown |
| Restella | R20143-1620P | FDA UDI | Class II | Unknown |
| Endoform Surface | SR05LG1010 | FDA UDI | U | Unknown |
| Endoform™ Natural Restorative Bioscaffold | 529314 | FDA UDI | U | Active |
| Ovitex® PRS | R20253-0717G | FDA UDI | Class II | Unknown |
| Myriad Ultra™ Reinforced BioScaffold – Permanent (PP) | LP04PP1525 | FDA UDI | Class II | Unknown |
| Restella | R20253-1122G | FDA UDI | Class II | Unknown |
| Endoform Antimicrobial Dermal Template | 629314 | FDA UDI | U | Active |
| Ovitex® PRS | R20143-2020P | FDA UDI | Class II | Unknown |
| Ovitex® PRS | R20143-0416P | FDA UDI | Class II | Unknown |
| Endoform Surface | SR03LG1020 | FDA UDI | Class II | Unknown |
| OviTex® IHR | F10243-1317I | FDA UDI | Class II | Active |
| Myriad Matrix™ Soft Tissue Bioscaffold | SR05LG2020US | FDA UDI | U | Active |
| Myriad Matrix™ Soft Tissue Bioscaffold | SR03LG0505US | FDA UDI | U | Active |
| Restella | R20143-0820P | FDA UDI | Class II | Unknown |
| Endoform Natural Dermal Template | 529316 | FDA UDI | U | Active |
| Restella | R20343-1622P | FDA UDI | Class II | Unknown |
| Myriad Matrix™ Soft Tissue Bioscaffold | SR02LG1020US | FDA UDI | U | Active |
| Restella | R20153-1620G | FDA UDI | Class II | Unknown |
| Endoform™ Natural Restorative Bioscaffold | 529302 | FDA UDI | U | Active |
| Ovitex® PRS | R20153-0416G | FDA UDI | Class II | Unknown |
| Endoform Antimicrobial Dermal Template | 629315 | FDA UDI | U | Active |
| Myriad Matrix™ Soft Tissue Bioscaffold | SR02LG2020US | FDA UDI | U | Active |
| Restella | R20253-1018G | FDA UDI | Class II | Unknown |
| Endoform™ Natural Restorative Bioscaffold | 529316 | FDA UDI | U | Active |
| Ovitex® PRS | R20153-2020G | FDA UDI | Class II | Unknown |
| Restella | R20243-1020P | FDA UDI | Class II | Unknown |
| Myriad Matrix™ Soft Tissue Bioscaffold | SR03LG0710US | FDA UDI | U | Active |
| Ovitex® PRS | R20243-1018P | FDA UDI | Class II | Unknown |
| Endoform™ Natural Restorative Bioscaffold | 529311 | FDA UDI | U | Active |
| Restella | R20243-0815P | FDA UDI | Class II | Unknown |
| Myriad Meshed Expandable Bioscaffold | MS01FH1822 | FDA UDI | U | Active |
| Symphony™ Proliferative Bioscaffold | CM04HA0505 | FDA UDI | U | Active |
| Myriad Matrix™ Soft Tissue Bioscaffold | SR02LG0505US | FDA UDI | U | Active |
| Restella | R30343-2022P | FDA UDI | Class II | Unknown |
| Myriad Matrix™ Soft Tissue Bioscaffold | SR03LG1020US | FDA UDI | U | Active |
| Restella | R20153-0820G | FDA UDI | Class II | Unknown |
Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.
FDA Recalls (21)
Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.
| Date | Recall No. | Class | Status | Reason |
|---|---|---|---|---|
| Apr 6, 2018 | Z-0417-2019 | — | terminated | Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers. |
| Apr 6, 2018 | Z-0429-2019 | — | terminated | Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers. |
| Apr 6, 2018 | Z-0419-2019 | — | terminated | Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers. |
| Apr 6, 2018 | Z-0422-2019 | — | terminated | Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers. |
| Apr 6, 2018 | Z-0420-2019 | — | terminated | Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers. |
| Apr 6, 2018 | Z-0433-2019 | — | terminated | Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers. |
| Apr 6, 2018 | Z-0415-2019 | — | terminated | Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers. |
| Apr 6, 2018 | Z-0431-2019 | — | terminated | Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers. |
| Apr 6, 2018 | Z-0423-2019 | — | terminated | Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers. |
| Apr 6, 2018 | Z-0421-2019 | — | terminated | Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers. |
| Apr 6, 2018 | Z-0425-2019 | — | terminated | Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers. |
| Apr 6, 2018 | Z-0428-2019 | — | terminated | Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers. |
| Apr 6, 2018 | Z-0432-2019 | — | terminated | Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers. |
| Apr 6, 2018 | Z-0426-2019 | — | terminated | Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers. |
| Apr 6, 2018 | Z-0416-2019 | — | terminated | Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers. |
| Apr 6, 2018 | Z-0434-2019 | — | terminated | Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers. |
| Apr 6, 2018 | Z-0418-2019 | — | terminated | Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers. |
| Apr 6, 2018 | Z-0427-2019 | — | terminated | Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers. |
| Apr 6, 2018 | Z-0435-2019 | — | terminated | Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers. |
| Apr 6, 2018 | Z-0424-2019 | — | terminated | Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers. |
| Apr 6, 2018 | Z-0430-2019 | — | terminated | Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers. |